Bixiye
Egrifta (tesamorelin) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 2421 - 2430 ee natiijooyinka 4128
Bixiye
Egrifta (tesamorelin) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Coagulation Factor VIIa - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Bixiye
Bonjesta, Diclegis - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Bempedoic Acid - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Bixiye
Bempedoic Acid - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Bixiye
QP80-21 BlueRideSM announces No-Load Pilot Program for Non-Emergency Medical Transportation (NEMT) in Greater Minnesota
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP81-21 Save the Date: Best Practices in Value-Based Arrangements
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP82-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Accrufer™ (ferric maltol)
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP83-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Kerendia®
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021